Serum amyloid A and misfolded transthyretin may be the two predictable biomarkers to relapsed/ refractory diffuse large B cell lymphoma

Asian J Surg. 2022 Jun;45(6):1301-1302. doi: 10.1016/j.asjsur.2022.01.131. Epub 2022 Mar 18.

¹ Department of Lymphoma, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China; Department of Lymphoma, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
² Department of Lymphoma, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China; Department of Lymphoma, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: dr_hou2001@163.com.

No abstract available

Publication types